LIFE SCIENCES DEVELOPMENT CAMPUS
0897.657.596 · rovalta.com · 21/09/2026
ACTIVE
LIFE SCIENCES DEVELOPMENT CAMPUS
Financial year 2025 · closed on 31/12/2025
Net result
317,1 k €
+169.4% YoY
Revenue
1,8 M €
+13.1% YoY
Equity
9,2 M €
+1.4% YoY
Workforce
2,4 ETP
0.0% YoY
Overview
What does LIFE SCIENCES DEVELOPMENT CAMPUS do?
LIFE SCIENCES DEVELOPMENT CAMPUS is a Public limited company incorporated in 2008. Its main activity is: Rental and operating of own or leased real estate. Its registered office is in Diepenbeek. It employs on average 2,4 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0897.657.596
Incorporation
25/04/2008
Legal form
Public limited company
Registered office
Agoralaan A-bis
3590 Diepenbeek · FlandreSee on map
3590 Diepenbeek · FlandreSee on map
Contributed capital
9 223 667,00 €
Latest accounts
31/12/2025
Average workforce
2,4 ETP
Activities (NACE)
Joint committees (2)
- 200
- 218
Signals
ProfitableSolid equityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||
| Revenue | 1,8 M € | +13.1% | 1,6 M € | +22.0% | 1,3 M € | +14.0% | 1,1 M € | +15.0% | 982,9 k € | +7.7% | 912,3 k € | +7.0% | 852,4 k € | +2.7% | 830 k € | +7.6% | 771,4 k € | +59.5% | 483,7 k € | -18.2% | 591,3 k € | -19.0% | 730,4 k € | +0.3% | 728,5 k € | +4.9% | 694,4 k € | +95.5% | 355,1 k € | +119% | 162,3 k € | +4638% | 3,4 k € |
| EBITDA | 860,6 k € | +16.6% | 738,2 k € | +74.2% | 423,8 k € | +582% | 62,1 k € | -69.5% | 204 k € | -34.4% | 310,7 k € | +1.8% | 305,2 k € | -6.0% | 324,6 k € | +5.9% | 306,6 k € | +1381% | -23,9 k € | -147% | 50,5 k € | -71.5% | 177,1 k € | +37.2% | 129,1 k € | +32.3% | 97,6 k € | +237% | -71,2 k € | +42.1% | -122,9 k € | -67.6% | -73,3 k € |
| Operating result | 229,8 k € | +177% | 83 k € | +225% | -66,6 k € | +84.2% | -420,6 k € | -45.0% | -290,1 k € | -122% | -131 k € | -19.0% | -110,1 k € | -9.5% | -100,5 k € | -35.1% | -74,4 k € | +79.3% | -359,4 k € | -4.3% | -344,4 k € | -136% | -145,8 k € | -5.1% | -138,7 k € | +16.1% | -165,4 k € | +40.4% | -277,4 k € | +11.1% | -311,9 k € | -158% | -121 k € |
| Net result | 317,1 k € | +169% | 117,7 k € | +227% | -92,7 k € | +75.8% | -382,9 k € | -51.2% | -253,2 k € | -88.5% | -134,3 k € | +2.3% | -137,5 k € | -3.1% | -133,3 k € | -5.3% | -126,6 k € | +73.4% | -475,6 k € | -6.7% | -445,5 k € | -77.6% | -250,9 k € | -45.1% | -172,9 k € | +36.8% | -273,5 k € | +44.6% | -493,9 k € | -0.3% | -492,4 k € | -107% | -237,6 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||
| Equity | 9,2 M € | +1.4% | 9 M € | -0.8% | 9,1 M € | +12.5% | 8,1 M € | -6.1% | 8,6 M € | -3.5% | 8,9 M € | +84.1% | 4,9 M € | -4.4% | 5,1 M € | +3.7% | 4,9 M € | -3.9% | 5,1 M € | -10.5% | 5,7 M € | -1.1% | 5,8 M € | -4.9% | 6,1 M € | +35.3% | 4,5 M € | +334% | 1 M € | -33.2% | 1,5 M € | -24.9% | 2,1 M € |
| Total assets | 12,1 M € | -3.2% | 12,5 M € | -6.2% | 13,4 M € | +3.4% | 12,9 M € | +5.0% | 12,3 M € | -5.3% | 13 M € | +36.9% | 9,5 M € | -1.6% | 9,7 M € | -0.0% | 9,7 M € | -9.8% | 10,7 M € | +3.6% | 10,3 M € | +5.1% | 9,8 M € | +1.6% | 9,7 M € | +25.2% | 7,7 M € | +25.2% | 6,2 M € | +7.2% | 5,8 M € | +2.3% | 5,6 M € |
| Cash | 401,6 k € | +65.4% | 242,8 k € | +190% | 83,7 k € | -95.1% | 1,7 M € | -14.0% | 2 M € | -0.3% | 2 M € | +536% | 313,3 k € | +395% | 63,3 k € | -82.0% | 352,3 k € | -60.3% | 887,6 k € | +111% | 421 k € | +101% | 209,8 k € | -62.6% | 561,5 k € | -67.5% | 1,7 M € | +539% | 270 k € | +14.0% | 236,8 k € | +74.7% | 135,5 k € |
| Debts | 3 M € | -14.8% | 3,5 M € | -18.1% | 4,2 M € | -11.5% | 4,8 M € | +32.4% | 3,6 M € | -6.6% | 3,9 M € | -12.3% | 4,4 M € | +2.3% | 4,3 M € | -7.8% | 4,7 M € | -14.8% | 5,5 M € | +22.1% | 4,5 M € | +11.9% | 4 M € | +11.5% | 3,6 M € | +22.1% | 3 M € | -37.3% | 4,7 M € | +20.5% | 3,9 M € | +20.0% | 3,3 M € |
| Other | |||||||||||||||||||||||||||||||||
| Workforce | 2,4 ETP | 0.0% | 2,4 ETP | -7.7% | 2,6 ETP | -29.7% | 3,7 ETP | -2.6% | 3,8 ETP | -2.6% | 3,9 ETP | +14.7% | 3,4 ETP | +13.3% | 3,0 ETP | +3.4% | 2,9 ETP | +11.5% | 2,6 ETP | -7.1% | 2,8 ETP | -6.7% | 3,0 ETP | +7.1% | 2,8 ETP | +40.0% | 2,0 ETP | +900% | 0,2 ETP | – | – | ||
Estimate
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 7 active · 19 ended
Active mandates
VEERLE SOMERS
ActiveLENY DE WINTER
ActiveActive
PIETER STINISSEN
ActiveTOM VANDEPUT
ActiveEnded mandates
TOM VANDEPUT
EndedTOM VANDEPUT
EndedFRANK SMEETS
EndedERIK GERITS
EndedAt this address
Other companies at this address
| Company | CBE no. |
|---|---|
Curalogx● Active | 1042.695.560 |
OEHOE DATA SCIENCE● Active | 0636.934.761 |
REJUVENATE BIOMED● Active | 0681.964.735 |
Rejuvenate Biomed Partners● Active | 0783.425.943 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/05/2026 | 21/05/2025 | 23/05/2024 | 25/05/2023 | 30/05/2022 | 25/05/2021 |
| General meeting | 24/04/2026 | 25/04/2025 | 26/04/2024 | 28/04/2023 | 29/04/2022 | 30/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
17 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 24/04/2026 | 22/05/2026 | Dutch | |
| Full model | 31/12/2024 | 25/04/2025 | 21/05/2025 | Dutch | |
| Full model | 31/12/2023 | 26/04/2024 | 23/05/2024 | Dutch | |
| Full model | 31/12/2022 | 28/04/2023 | 25/05/2023 | Dutch | |
| Full model | 31/12/2021 | 29/04/2022 | 30/05/2022 | Dutch | |
| Full model | 31/12/2020 | 30/04/2021 | 25/05/2021 | Dutch | |
| Full model | 31/12/2019 | 24/04/2020 | 18/05/2020 | Dutch | |
| Full model | 31/12/2018 | 26/04/2019 | 15/05/2019 | Dutch | |
| Full model | 31/12/2017 | 27/04/2018 | 23/05/2018 | Dutch | |
| Full model | 31/12/2016 | 28/04/2017 | 18/05/2017 | Dutch | |
| Full model | 31/12/2015 | 12/05/2016 | 27/05/2016 | Dutch | |
| Full model | 31/12/2014 | 24/04/2015 | 03/06/2015 | Dutch | |
| Full model | 31/12/2013 | 25/04/2014 | 21/05/2014 | Dutch | |
| Full model | 31/12/2012 | 17/05/2013 | 12/06/2013 | Dutch | |
| Full model | 31/12/2011 | 27/04/2012 | 03/05/2012 | Dutch | |
| Full model | 31/12/2010 | 29/04/2011 | 31/05/2011 | Dutch | |
| Full model | 31/12/2009 | 06/05/2010 | 31/05/2010 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 7 active · 19 ended
Active mandates
VEERLE SOMERS
ActiveLENY DE WINTER
ActiveActive
PIETER STINISSEN
ActiveTOM VANDEPUT
ActiveEnded mandates
TOM VANDEPUT
EndedTOM VANDEPUT
EndedFRANK SMEETS
EndedERIK GERITS
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates26/06/2026ONTSLAGEN - BENOEMINGEN
- Mandates08/05/2026ONTSLAGEN - BENOEMINGEN
- Mandates03/06/2024ONTSLAGEN - BENOEMINGEN
- Capital / shares08/01/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Capital / shares22/09/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates24/08/2023ONTSLAGEN - BENOEMINGEN
- Mandates17/08/2022ONTSLAGEN - BENOEMINGEN
- Mandates24/09/2021ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025317,1 k €↑
- 2024Annual accounts 2024117,7 k €↑
- 2023Annual accounts 2023-92,7 k €↑
- 2022Annual accounts 2022-382,9 k €↓
- 2021Annual accounts 2021-253,2 k €↓
- 2020Annual accounts 2020-134,3 k €↑
- 2019Annual accounts 2019-137,5 k €↓
- 2018Annual accounts 2018-133,3 k €↓
- 2017Annual accounts 2017-126,6 k €↑
- 2016Annual accounts 2016-475,6 k €↓
- 2015Annual accounts 2015-445,5 k €↓
- 2014Annual accounts 2014-250,9 k €↓
- 2013Annual accounts 2013-172,9 k €↑
- 2012Annual accounts 2012-273,5 k €↑
- 2011Annual accounts 2011-493,9 k €↓
- 2010Annual accounts 2010-492,4 k €↓
- 2009Annual accounts 2009-237,6 k €
- 25/04/2008IncorporationPublic limited company